跳到正文
原文
MedPage Today·· 3 小时前AI 评分50

癌症治疗推动保险成本上涨;非营利医院财务状况堪忧

Cancer Care Driving Insurance Costs; Unnecessary Chemo? Profiting by Non-Profits

AI 导读

调查显示癌症治疗是保险成本上涨的主要原因;加州体操运动员因肌肉量高幸存胰腺癌;非营利医院支出低于税收减免;TROP-2靶向抗体药物在晚期胃食管腺癌中显著延长生存期;肽疫苗在复发急性髓系白血病维持治疗中表现优异。

正文

— News, features, and commentary about cancer-related issues

November 20, 2026 • 2 min read

In a survey of more than 3,700 U.S. companies, 7 of 10 respondents cited cancer care as the top driver of increases in health insurance premiums. (Axios)

After "a really scary few months," TV celebrity and model Jax Taylor revealed he had surgery for kidney cancer, diagnosed when he sought medical care for what he thought was a kidney stone. (People)

An Oregon jury found a radiology group and its partner hospital liable for missing an incidental lung cancer on a breast MRI scan and awarded nearly $8 million to the patient's estate. (The Oregonian)

A study from Arizona showed endometrial cancer incidence continuing to increase, disproportionately so in younger Native Americans and Hispanics. (University of Arizona Cancer Center)

Is chemotherapy still necessary for endometrial cancer treated with a PD-L(1) inhibitor? (Clinical Trial Vanguard)

England's National Health Service formally apologized to 20 patients with brain tumors treated with unnecessary long-term chemotherapy that severely harmed them, all under the care of the same now-retired physician. (The Guardian)

A California bodybuilder never imagined that his muscle mass would help him survive pancreatic cancer. (Cedars-Sinai)

Fewer than 5% of patients with upper tract urothelial carcinoma, a cancer common to patients with Lynch syndrome, had germline testing with a multigene hereditary cancer panel, despite guideline support for universal testing in such patients. (JCO Oncology Practice)

Help to decide whether you are a candidate for lung cancer screening. (UT Southwestern Medical Center)

Although lung cancer survival has improved substantially, more than 20% of patients nationwide receive no treatment after diagnosis, according to the American Lung Association's annual report.

Some BRCA2 gene variants confer a lower risk of breast cancer than previously recognized, which could help personalize risk assessment and treatment. (Mayo Clinic)

New insight into the origin of arthritis flares that can occur during cancer immunotherapy and interfere with treatment. (Yale School of Medicine)

More than half of non-profit hospitals spent less on their communities than they received in tax exemptions, according to a survey by the Lown Institute.

In a phase III study, patients with advanced gastroesophageal adenocarcinoma lived significantly longer when treated in third-line or later with the TROP-2-targeted antibody-drug conjugate sacituzumab tirumotecan instead of physician's choice of standard therapies, Merck announced.

Patients with relapsed acute myeloid leukemia in remission lived significantly longer if they received maintenance treatment with an investigational peptide vaccine instead of standard therapies, according to phase III results reported by Sellas Life Sciences.

来源:MedPage Today · medpagetoday.com